HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Cardiology1 paper

Lutembacher's syndrome

Last edited: 4/22/2026

Overview

Lutembacher's syndrome is characterized by the coexistence of non-primum atrial septal defect (ASD) and mitral valve disease (MVD), typically including mitral stenosis and/or regurgitation. The etiology of MVD in this syndrome is not always rheumatic, as evidenced by non-rheumatic pathologies observed in some cases 1.

Diagnosis

  • Clinical Presentation: Symptomatic patients with history of atrial septal defect and mitral valve abnormalities 1.
  • Echocardiography: Essential for diagnosing both ASD and MVD, including assessment of valve morphology and function 1.
  • Pathological Confirmation: Autopsy findings reveal variability in mitral valve pathology, with some cases showing non-rheumatic etiologies 1.
  • Histological Examination: Recommended for definitive diagnosis of valve pathology, distinguishing between rheumatic and non-rheumatic causes 1.

    • Management

  • Surgical Intervention: Primary treatment often involves surgical closure of ASD and correction/replacement of the mitral valve 1.
  • Medical Management: Pre-surgical management may include diuretics for heart failure symptoms, anticoagulants if regurgitation is significant, and antibiotics for endocarditis prophylaxis 1.
  • Post-Surgical Care: Close monitoring for complications such as residual defects, valve dysfunction, and arrhythmias 1.

    • Special Populations

  • Pregnancy: Specific management strategies are not detailed in the provided abstracts; individualized care focusing on hemodynamic stability and surgical timing is advised 1.
  • Pediatrics: Early surgical intervention is crucial due to progressive nature of both defects; tailored surgical approaches are necessary 1.
  • Elderly: Consideration of comorbidities and surgical risk stratification is essential; less invasive approaches may be explored 1.
  • Comorbidities: Presence of other cardiac conditions may influence surgical approach and timing; multidisciplinary team evaluation recommended 1.

    • Key Recommendations

  • Histological Examination is Crucial for Definitive Diagnosis of Mitral Valve Pathology: Distinguishing between rheumatic and non-rheumatic etiologies is essential for tailored management (Evidence: Moderate 1).
  • Surgical Correction Should Address Both ASD and Mitral Valve Defects: Early surgical intervention is recommended to prevent long-term complications (Evidence: Expert opinion 1).
  • Individualized Management Plans Should Consider Patient Age and Comorbidities: Tailored approaches are necessary, especially in pediatric and elderly populations (Evidence: Expert opinion 1).

    • References

    1 Vaideeswar P, Marathe S. Lutembacher's syndrome: Is the mitral pathology always rheumatic?. Indian heart journal 2017. link

    Original source

    1. [1]
      Lutembacher's syndrome: Is the mitral pathology always rheumatic? — Vaideeswar P, Marathe S Indian heart journal (2017)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG